BACKGROUND BRIEFING: How are we treating COVID-19 in Australia?

Embargoed until: Publicly released: 2021-09-28 10:00

Australia; NSW; VIC

Photo by Myriam Zilles on Unsplash

*BRIEFING RECORDING NOW AVAILABLE* Medications to treat COVID-19 have been a contentious issue since the beginning of the pandemic, with some members of the public latching on to unproven medications like hydroxychloroquine and now ivermectin. As misinformation circulates online, international and Australian researchers are hard at work gathering evidence of what works and what doesn't to treat growing caseloads as we move away from COVID zero. With each new medication comes a dilemma; how do we secure enough for Australia when the whole world needs the same thing?

News release

From: Australian Science Media Centre

The briefing will discuss the following issues:

What medications work for treating COVID-19? What have we already ruled out?
What research is being done in Australia to identify potential COVID-19 treatments?
How can Australia secure enough supply of medications for COVID-19 as our cases rise?

Speakers:

Professor Julian Elliott is Executive Director of the National COVID-19 Clinical Evidence Taskforce and a Senior Research Fellow at Cochrane Australia, Monash University
Professor Joshua Davis is a clinician researcher at Menzies School of Health Research and a Co-ordinating Principal Investigator on the ASCOT Australasian COVID-19 Trial
Professor Andrew McLachlan is the Head of School and Dean of Pharmacy at the University of Sydney

Date: Tue 28 Sep 2021
Start Time: 10:00am AEST
Duration: Approx 45 min
Venue: Online - Zoom

Attachments

Note: Not all attachments are visible to the general public. Research URLs will go live after the embargo ends.

Briefing recording Australian Science Media Centre, Web page

Journal/
conference:

Organisation/s: Australian Science Media Centre

Funder: N/A

Media Contact/s

Contact details are only visible to registered journalists.